Perineural Injection Treatment for Shoulder Pain
CompletedNot applicableNCT07559058
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Shoulder pain is a common musculoskeletal condition that can lead to significant functional limitation and reduced quality of life. Conventional treatments often provide limited or temporary relief, highlighting the need for alternative approaches targeting peripheral pain mechanisms. This study aims to evaluate the effectiveness of Perineural Injection Treatment (PIT) compared to Transcutaneous Electrical Nerve Stimulation (TENS) in reducing pain and improving functional outcomes in patients with subacute or chronic shoulder pain. In this randomized controlled trial, participants are assigned to receive either PIT or TENS, in addition to a standardized exercise program. The intervention is delivered over two sessions within a two-week period. Pain intensity is assessed using the Numeric Rating Scale (NRS), and functional outcomes are measured using the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire. The results of this study are expected to provide evidence on the comparative effectiveness of PIT and TENS, and to support clinical decision-making in the management of shoulder pain.
Study details
- Official title
- Effect of Perineural Injection Treatment on Pain Intensity and Functional Outcomes in Patients With Shoulder Pain: A Randomized Controlled Trial
- Conditions
- Shoulder Pain
- Rotator Cuff Disorders
- Adhesive Capsulitis
- Interventions
- Drug: Dextrose 5% Injection
- Device: Transcutaneous Electrical Nerve Stimulation (TENS)
- Behavioral: Exercise Program
- Sponsor
- Rizki Darmawan
- Organization
- Hasanuddin University
- Start date
- 2025-10-01
- Primary completion
- 2026-01-31
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Indonesia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults aged 18-65 years * Patients with subacute or chronic shoulder pain * Pain intensity ≥ 3 on the Numeric Rating Scale (NRS) * Diagnosed with shoulder conditions such as adhesive capsulitis, rotator cuff tendinopathy or tear, glenohumeral osteoarthritis, acromioclavicular joint sprain, or biceps tendinopathy * Able to provide informed consent Exclusion Criteria: * History of injection therapy or use of analgesic medications within one week prior to intervention * Presence of neurological or systemic diseases affecting upper limb function * Pregnancy * Contraindications to injection therapy (e.g., infection at injection site, needle phobia, allergy to dextrose) * Refusal to participate or inability to complete the study protocol
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07559058